Can Berberine Serve As a New Therapy for Parkinson’S Disease?

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share By

Can Berberine Serve As a New Therapy for Parkinson’S Disease? Publisher Pubmed

Dadgostar E^{1, 2} ; Moghanlou M³ ; Parvaresh M⁴ ; Mohammadi S⁵ ; Khandan M⁶ ; Aschner M⁷ ; Mirzaei H⁸ ; Tamtaji OR^{9, 10}

Source: Neurotoxicity Research Published:2022

Abstract

Parkinson’s disease (PD) is a neurodegenerative disorder characterized by dopaminergic neurodegeneration and deposition of alpha-synuclein. Mechanisms associated with PD etiology include oxidative stress, apoptosis, autophagy, and abnormalities in neurotransmission, to name a few. Drugs used to treat PD have shown significant limitations in their efficacy. Therefore, recent focus has been placed on the potential of active plant ingredients as alternative, complementary, and efficient treatments. Berberine is an isoquinoline alkaloid that has shown promise as a pharmacological treatment in PD, given its ability to modulate several molecular pathway associated with the disease. Here, we review contemporary knowledge supporting the need to further characterize berberine as a potential treatment for PD. © 2022, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Related Docs

View other Related Docs

1. Probiotics and the Treatment of Parkinson's Disease: An Update, Cellular and Molecular Neurobiology (2022)

2. Therapeutic Effects of Berberine in Metabolic Diseases and Diabetes Mellitus, Revista Brasileira de Farmacognosia (2021)

3. Targeting of Oncogenic Signaling Pathways by Berberine for Treatment of Colorectal Cancer, Medical Oncology (2020)

Experts (# of related papers)

View all Related Experts

Gholamreza Askari (4)

Mohammad Bagherniya (3)

Other Related Docs

4. Barberry (Berberis Vulgaris): Composition and Use of Extracts in Cancer Studies, Ancient and Traditional Foods, Plants, Herbs and Spices used in Cancer (2023)

5. The Therapeutic Effects of Berberine for Gastrointestinal Cancers, Asia-Pacific Journal of Clinical Oncology (2024)

6. The Effect of Barberry (Berberis Vulgaris L.) on Glycemic Indices: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, Complementary Therapies in Medicine (2020)

7. Bio (6-Bromoindirubin-3′-Oxime) Gsk3 Inhibitor Induces Dopaminergic Differentiation of Human Immortalized Renvm Cells, Comparative Clinical Pathology (2018)

8. Inhibitors of Α-Synuclein Fibrillation and Oligomer Toxicity in Rosa Damascena: The All-Pervading Powers of Flavonoids and Phenolic Glycosides, ACS Chemical Neuroscience (2020)

9. Non-Coding Rnas and Neurodegenerative Diseases: Information of Their Roles in Apoptosis, Molecular Neurobiology (2024)

10. Therapeutic Potential of Berries in Age-Related Neurological Disorders, Frontiers in Pharmacology (2024)

11. The Effects of Berberis Vulgaris Juice on Insulin Indices in Women With Benign Breast Disease: A Randomized Controlled Clinical Trial, Iranian Journal of Pharmaceutical Research (2018)

12. The Role of Phytochemicals in Sepsis: A Mechanistic and Therapeutic Perspective, BioFactors (2021)

13. Medicinal Plants and Bioactive Natural Products As Inhibitors of Nlrp3 Inflammasome, Phytotherapy Research (2021)

14. The Effects of Synbiotic Supplementation on Oxidative Stress Markers, Mental Status, and Quality of Life in Patients With Parkinson's Disease: A Double-Blind, Placebo-Controlled, Randomized Controlled Trial, Journal of Functional Foods (2023)

15. Effects of Cinnamon Oil and Its Main Constituents, Cinnamic Acid and Cinnamaldehyde, on 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Neurodegeneration in Pc-12 Cells; [Efectos Del Aceite De Canela Y Sus Principales Componentes, Acido Cinamico Y Cinamaldehido En La Neurodegeneracion Inducida Por 1-Metil-4-Fenil-1,2,3,6-Tetrahidropiridina En Celulas Pc 12], Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas (2023)

16. The Effect of Berberine Supplementation on Lipid Profile and Obesity Indices: An Umbrella Review of Meta-Analysis, PharmaNutrition (2023)

Style	Citing Format
MLA	Dadgostar E, et al.. "Can Berberine Serve As a New Therapy for Parkinson’S Disease?." Neurotoxicity Research, vol. 40, no. 4, 2022, pp. 1096-1102.
APA	Dadgostar E, Moghanlou M, Parvaresh M, Mohammadi S, Khandan M, Aschner M, Mirzaei H, Tamtaji OR (2022). Can Berberine Serve As a New Therapy for Parkinson’S Disease?. Neurotoxicity Research, 40(4), 1096-1102.
Chicago	Dadgostar E, Moghanlou M, Parvaresh M, Mohammadi S, Khandan M, Aschner M, Mirzaei H, Tamtaji OR. "Can Berberine Serve As a New Therapy for Parkinson’S Disease?." Neurotoxicity Research 40, no. 4 (2022): 1096-1102.
Harvard	Dadgostar E et al. (2022) 'Can Berberine Serve As a New Therapy for Parkinson’S Disease?', Neurotoxicity Research, 40(4), pp. 1096-1102.
Vancouver	Dadgostar E, Moghanlou M, Parvaresh M, Mohammadi S, Khandan M, Aschner M, et al.. Can Berberine Serve As a New Therapy for Parkinson’S Disease?. Neurotoxicity Research. 2022;40(4):1096-1102.
BibTex	@article{ author = {Dadgostar E and Moghanlou M and Parvaresh M and Mohammadi S and Khandan M and Aschner M and Mirzaei H and Tamtaji OR}, title = {Can Berberine Serve As a New Therapy for Parkinson’S Disease?}, journal = {Neurotoxicity Research}, volume = {40}, number = {4}, pages = {1096-1102}, year = {2022} }
RIS	TY - JOUR AU - Dadgostar E AU - Moghanlou M AU - Parvaresh M AU - Mohammadi S AU - Khandan M AU - Aschner M AU - Mirzaei H AU - Tamtaji OR TI - Can Berberine Serve As a New Therapy for Parkinson’S Disease? JO - Neurotoxicity Research VL - 40 IS - 4 SP - 1096 EP - 1102 PY - 2022 ER -

Science Communicator Platform

Authors

Abstract